Definium Therapeutics Inc. monthly returns
Definium Therapeutics Inc. has averaged 13.68% per month, positive in 47% of months. Month-by-month returns for Definium Therapeutics Inc. (DFTX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Definium Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -15.7% | |
| Sep 2026 | -4.2% | |
| Aug 2026 | -8.7% | |
| Jul 2026 | -7.5% | |
| Jun 2026 | +94.5% | |
| May 2026 | +10.6% | |
| Apr 2026 | +15.8% | |
| Mar 2026 | +8.3% | |
| Feb 2026 | +3.4% | |
| Jan 2026 | +26.1% | |
| Dec 2025 | +5.8% | |
| Nov 2025 | -10.9% | |
| Oct 2025 | +20.4% | |
| Sep 2025 | +32.8% | |
| Aug 2025 | -2.3% | |
| Jul 2025 | +40.1% | |
| Jun 2025 | -10.6% | |
| May 2025 | +13.6% | |
| Apr 2025 | +9.2% | |
| Mar 2025 | -12.9% | |
| Feb 2025 | -1.0% | |
| Jan 2025 | -2.4% | |
| Dec 2024 | -14.8% | |
| Nov 2024 | +29.7% | |
| Oct 2024 | +10.7% | |
| Sep 2024 | -6.1% | |
| Aug 2024 | -34.6% | |
| Jul 2024 | +28.4% | |
| Jun 2024 | -18.1% | |
| May 2024 | -7.6% | |
| Apr 2024 | +1.3% | |
| Mar 2024 | +64.5% | |
| Feb 2024 | +48.1% | |
| Jan 2024 | +5.5% | |
| Dec 2023 | +10.9% | |
| Nov 2023 | +28.9% | |
| Oct 2023 | -18.2% | |
| Sep 2023 | -24.6% | |
| Aug 2023 | -15.8% | |
| Jul 2023 | +38.1% | |
| Jun 2023 | +0.8% | |
| May 2023 | -7.3% | |
| Apr 2023 | +20.5% | |
| Mar 2023 | -14.8% | |
| Feb 2023 | +9.1% | |
| Jan 2023 | +55.0% | |
| Dec 2022 | -13.7% | |
| Nov 2022 | -13.0% | |
| Oct 2022 | -16.3% | |
| Sep 2022 | -70.1% | |
| Aug 2022 | +12.4% | |
| Jul 2022 | +8.6% | |
| Jun 2022 | -29.3% | |
| May 2022 | +13.1% | |
| Apr 2022 | -27.9% | |
| Mar 2022 | -9.0% | |
| Feb 2022 | +8.9% | |
| Jan 2022 | -18.8% | |
| Dec 2021 | -30.3% | |
| Nov 2021 | -21.4% | |
| Oct 2021 | +8.2% | |
| Sep 2021 | -19.4% | |
| Aug 2021 | -5.6% | |
| Jul 2021 | -11.3% | |
| Jun 2021 | +1.5% | |
| May 2021 | -13.0% | |
| Apr 2021 | +40.1% | |
| Mar 2021 | -16.0% | |
| Feb 2021 | +12.5% | |
| Jan 2021 | -3.3% | |
| Dec 2020 | +84.2% | |
| Nov 2020 | +114.2% | |
| Oct 2020 | +29.5% | |
| Sep 2020 | +63.1% | |
| Aug 2020 | +14.7% | |
| Jul 2020 | -14.2% | |
| Jun 2020 | -6.3% | |
| May 2020 | -11.8% | |
| Apr 2020 | -19.6% | |
| Mar 2020 | +1020.0% | |
| Feb 2020 | +0.0% | |
| Jan 2020 | -10.7% | |
| Dec 2019 | +16.7% | |
| Nov 2019 | -27.3% | |
| Oct 2019 | +29.4% | |
| Sep 2019 | +8.5% | |
| Aug 2019 | +370.0% | |
| Jul 2019 | -83.3% | |
| Jun 2019 | +11.1% | |
| May 2019 | -18.2% | |
| Apr 2019 | +11.9% | |
| Mar 2019 | +13.5% | |
| Feb 2019 | +4.0% | |
| Jan 2019 | +13.6% | |
| Dec 2018 | -18.5% | |
| Nov 2018 | -37.2% | |
| Oct 2018 | +2.4% | |
| Sep 2018 | -16.0% | |
| Aug 2018 | +40.8% | |
| Jul 2018 | -21.1% | |
| Jun 2018 | -40.0% | |
| May 2018 | +0.0% | |
| Apr 2018 | -2.6% | |
| Mar 2018 | +7.7% | |
| Feb 2018 | -37.6% | |
| Jan 2018 | -22.9% | |
| Dec 2017 | +8.0% | |
| Nov 2017 | -2.1% | |
| Oct 2017 | -20.8% | |
| Sep 2017 | -6.3% | |
| Aug 2017 | -23.9% | |
| Jul 2017 | -3.3% | |
| Jun 2017 | +1.0% | |
| May 2017 | -14.6% | |
| Apr 2017 | -28.6% | |
| Mar 2017 | -18.0% | |
| Feb 2017 | +52.2% | |
| Jan 2017 | +22.0% | |
| Dec 2016 | +58.2% |
Monthly total return (since Nov 2021)#
Definium Therapeutics Inc. returns by calendar month#
Every month of every year since 2017, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -15.66% — 7th of 10 Octobers since 2017 at the last close; the average October returned +5.0%.
| Month | −1020%0+1020% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.4% | +1.5% | 50% | +55.0% 2023 | -22.9% 2018 | |
| Feb | +10.0% | +6.5% | 70% | +52.2% 2017 | -37.6% 2018 | |
| Mar | +104.3% | -0.7% | 50% | +1020.0% 2020 | -18.0% 2017 | |
| Apr | +2.0% | +5.3% | 60% | +40.1% 2021 | -28.6% 2017 | |
| May | -3.5% | -7.4% | 30% | +13.6% 2025 | -18.2% 2019 | |
| Jun | +0.5% | -2.7% | 50% | +94.5% 2026 | -40.0% 2018 | |
| Jul | -2.6% | -5.4% | 40% | +40.1% 2025 | -83.3% 2019 | |
| Aug | +34.7% | -3.9% | 40% | +370.0% 2019 | -34.6% 2024 | |
| Sep | -4.2% | -6.2% | 30% | +63.1% 2020 | -70.1% 2022 | |
| Oct | +5.0% | +8.2% | 67% | +29.5% 2020 | -20.8% 2017 | |
| Nov | +6.8% | -10.9% | 33% | +114.2% 2020 | -37.2% 2018 | |
| Dec | +5.4% | +5.8% | 56% | +84.2% 2020 | -30.3% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from DFTX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Definium Therapeutics Inc.'s average monthly return?
- Definium Therapeutics Inc. (DFTX) has averaged about 13.68% per month, positive in roughly 47% of months. The best month was Mar 2020 (+1020.0%) and the worst was Jul 2019 (-83.3%).
